Inclan, Paul M.
Rodeo, Scott A.
Article History
Accepted: 18 April 2024
First Online: 29 April 2024
Compliance with Ethical Standards
:
: Dr. Inclan has no disclosures related to this manuscript. Dr. Rodeo received research funding from the Orthopaedic Research and Education Foundation, NIH, and Toulmin Foundation. He receives consulting fees from Novartis Pharmaceuticals and Enovis. He is the Associate Editor for the American Journal of Sports Medicine and Vice Preseident of the Biologics Association. He has stock or stock options from Jannu Therapeutics, Overture, Brainbox, and Forme.
: This article does not contain any studies with human or animal subjects performed by any of the authors.